Revised warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk.
Read more: Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication - Strengthened Kidney Warnings